3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1
2
Phase 2
1
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Small Cell Lung Carcinoma
1
Extensive Stage Small Cell Lung Cancer
1
Interventions
Specimen Handling
146
pembrolizumab
120
Magnetic Resonance Spectroscopy
117
Cyclophosphamide
114
Biopsy
97
fludarabine
88
Nivolumab
52
Carboplatin
51
Cisplatin
47
Gemcitabine
46
venetoclax
41
Radiotherapy
41
Paclitaxel
40
Cetuximab
40
fludarabine phosphate
39
Ipilimumab
34
atezolizumab
33
Fluorouracil
33
Bevacizumab
33
Oxaliplatin
27
Leucovorin
27
Dexamethasone
27
durvalumab
26
X-Rays
25
Irinotecan
25
Radiation
24
Cytarabine
24
Azacitidine
24
Injections
22
Temozolomide
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
AMG 757
×
90 days
×
Clear all
NCT06598306
2026-05-29
DeLLphi-308
Amgen
Phase 1
Recruiting
220 enrolled
NCT07037758
2026-05-29
DeLLphi-311
Amgen
Phase 1
Recruiting
380 enrolled